Tagged with Pharmaceuticals

pharmaceuticals Dr Martin Favle, Chairman of Bogin – the Dutch Generic Medicine Industry Association, representing the interests of the generic medicines industry in the Netherlands – shares his fears about slow growth in the Dutch generics market and the state of the biosimilars market. You were quoted in the media last year saying ‘2014 was a…

marketing Ivelisse Casillas, founder of PharMaCon, Inc. talks about the challenges of marketing and advertising pharmaceuticals products in Puerto Rico. She founded the company in 2000 to provide advertising, legal and medical expertise to the sector. What are the main advertising challenges that your clients face with which you can help them? The biggest…

Turkey PharmaBoardroom talked to Sr. Managing Director of Medtronic Turkey, Ayhan Ozturk about improving patient outcomes, how the company introduced a whole new standard on integrated healthcare, and their recent USD $25 million investment in a training facility.  Medtronic recently invested USD $25 million in a state-of-the-art training facility/Center of Innovation, which opened…

universal healthcare Berlin Pharmaceutical Industry’s CEO, Amal Naj, explains how he has grown the company, its next regional and medical targets, and his vision for its future. What has led to Berlin Pharmaceutical’s success over the last five years?    In 2010, the market was going through a major transition due to the progressive…

government PharmaBoardroom met the Secretary General of the Thai FDA and the Senior Expert on Pharmaceutical Standards at the FDA. They explained the FDA’s role in Thailand’s pharma market, what the organization is doing for Thai copyright rights, how it is promoting international investment and integration within the ASEAN Economic Community. Please introduce…

manufacturing The chancellor of the Medical Sciences Campus of the University of Puerto Rico discusses the medical R&D projects the university is currently involved in, the fields in which the island has the most potential, and how the institution is tailoring its academic offer to suit the local needs of the…

pharma Ana Myriam Irizarry, plant manager for LifeScan in Puerto Rico, discusses the competitive nature of the facility’s production of diabetes test strips and the immense talent that Puerto Rico has to offer in terms of manufacturing talent. What makes LifeScan’s test strips so innovative? It is the quality of our…

Puerto Rico PharmaBoardroom spoke to Osvaldo Caro, President, Chairman and CEO of ReComS, about the legal side of the pharmaceuticals sector in Puerto Rico. What are ReComS’ defining characteristics? ReComS is the only company in Puerto Rico that provides consulting services through a combination of attorneys and other professionals. Our staff is divided…

Puerto Rico Enrique Alejandro, Director and Team Leader (Finance) of Pfizer Puerto Rico discusses the pharma company’s manufacturing assets in the country. He stresses the importance of innovation as a key to staying competitive in today’s industry. What products are being manufactured in Pfizer’s Puerto Rico facilities? In Barceloneta, our site produces Active Product…

pharmaceuticals With a wealth of experience in different countries around the world, Christophe Piganiol came to Korea as general manager of Zuellig Pharma in 2010. Today he discusses the importance of transparency in a volatile market and the introduction of new business models to satisfy customer demand. What were your impressions…

pharmaceuticals The general manager gives tips on how to succeed in the Algerian market and explains how there is something in it for all types of business. Can you introduce yourself, introduce the CCIAF, and how the Chamber of Commerce has evolved over times?  The CCIAF is a non-profit organization, approved by…

pharmaceuticals Boehringer Ingelheim is turning 130 in 2015. Miguel Salazar, president and country managing director for Mexico, explains how he is steering the company to bypass the currents of the ever-changing Mexican market to lead the company to enter the top five in the coming future. How has the pharmaceutical industry…